The CVS-Aetna merger creates a price-setting behemoth for medications.
A growing insulin crisis adds urgency to efforts to radically reform the prescription drug pipeline.
The Senate Democrats succeeded in throwing Al Franken under the bus. They may come to regret it.
Robert Kuttner is co-founder and co-editor of The American Prospect, and professor at Brandeis University's Heller School. His latest book is Debtors' Prison: The Politics of Austerity Versus Possibility. He writes columns for The Huffington Post, The Boston Globe and the New York Times international edition.